Video
16 Jul 2024

Patient Centric Dosage Forms: Enhancing Acceptance and Adherence in Special Populations

The following session has been SOLD OUT. For any inquiries, please contact a member of staff on the day Kickstart your CPHI North America with a coffee and pastry, connect with your peers, and listen to exclusive content surrounding patient-centric development

The challenge of ensuring medication acceptance and adherence is particularly acute in special populations, such as pediatric and geriatric groups. These populations exhibit distinct pharmacokinetic and pharmacodynamic profiles due to their unique age-related physiological and biopharmaceutical characteristics. Consequently, the standard approaches to medication formulation often fall short of addressing their specific needs.

This presentation will explore the unique aspects of pediatric and geriatric populations, highlighting the limitations encountered in the design and development of dosage forms tailored for them, and how those challenges are overcome. A significant focus will be placed on the strategies that can be employed to overcome these challenges, with an emphasis on Adare’s platform technologies.

Through this discussion, we aim to shed light on the critical factors that must be considered in the development of effective, patient-friendly pharmaceutical formulations for pediatric and geriatric patients.

Content provided by our supplier

Adare Pharma Solutions

  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Out-licensing specialist
Packaging & drug delivery
View company profile

Other Content from Adare Pharma Solutions (21)

  • Providing solutions for special populations – CPHI North America Interview

    News Providing solutions for special populations – CPHI North America Interview

    In Philadelphia in May on site at CPHI North America we were able to meet with some of our speakers regarding their presentations. In the following interview Srinivasan Shanmugam, Executive Director, Pharmaceutical Sciences, Business Support, and New Technologies at Adare Pharma Solutions discusses his breakfast session. 
    10 Jun 2024
  • Adare Pharma Solutions Interactive Brochure

    Brochure Adare Pharma Solutions Interactive Brochure

    Explore Adare's capabilities through our interactive brochure, showcasing our technology-driven CDMO with integrated end-to-end services. With extensive capacity, experience, and a global track record, Adare is your partner for small molecule oral solid dose success.

  • A Start-Up’s Guide to Choosing Their First CDMO: Breakfast Session Bulletin

    News A Start-Up’s Guide to Choosing Their First CDMO: Breakfast Session Bulletin

    Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners, the CPHI North America Breakfast Sessions had something for everyone looking to fill their brains and their stomachs. 
    3 May 2023
  • Scientific Briefing - Formulation of Aqueous Core Poly (Lactic Acid) Microcapsules

    Brochure Scientific Briefing - Formulation of Aqueous Core Poly (Lactic Acid) Microcapsules

    Poly (lactic acid), or PLA, is a biodegradable, biocompatible polyester commonly used in many medical, pharmaceutical, and biotechnology products. The molecular weight of PLA can be tailored to impart various degradation kinetics and subsequent release profiles. The ability to make microcapsules with a thin PLA shell, however, is non-existent in the controlled release space. Here, using a proprietary Stratμm® technology, we have created 50 μm capsules with an aqueous core and thin PLA shell. The microcapsules have implications for encapsulating water-soluble molecules such as peptides and proteins, which can be released with a discrete pulse, or slow ramp in release rate.
  • CPHI North America 2023 – From the Floor

    News CPHI North America 2023 – From the Floor

    Follow along for live updates from the Content team as we bring you the latest from CPHI North America 2023 - from session talks, panel discussions, interviews, and more, there's a lot to discover with CPHI Online at the Pennsylvania Convention Center! 
    24 Apr 2023
  • Scientific Briefing - Formulations of Monodisperse Controlled-Release Quetiapine Microspheres

    Brochure Scientific Briefing - Formulations of Monodisperse Controlled-Release Quetiapine Microspheres

    Adare’s Optimµm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time. The study herein uses Adare technology to fabricate monodisperse quetiapine microparticles to investigate the effects of formulation and size on the release profile of the API.
  • The Top 5 Industry Content Reads on CPHI Online

    News The Top 5 Industry Content Reads on CPHI Online

    If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner. 

    The Company Showcase profiles offer a library of free to access, downloadable content, including videos and webinars, reports, whitepapers and product brochures, from the Pharma suppliers and service providers you’d look to meet at our events.

    30 Nov 2020
  • Scientific Briefing - Dissolution Development of Parvulet Technology Oral Tablets

    Brochure Scientific Briefing - Dissolution Development of Parvulet Technology Oral Tablets

    Parvulet® Technology is a patented oral dosage form capable of being dispensed to patients in tablet or powder formats, and converted into a semi-solid at the time of dosage through activation with water. The final dosage is easily administered, as a soft food like texture, ideal for pediatric and geriatric populations (including those with dysphagia). The Parvulet® technology can be combined with our taste-masking and controlled release technologies, providing greater flexibility in advancing patient centric solutions.
  • The Top 5 Industry Content Reads on CPHI Online

    News The Top 5 Industry Content Reads on CPHI Online

    If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner. The Company Showcase profiles offer a library of free to access, downloadable content, including videos and webinars, reports, whitepapers and product brochures, from the Pharma suppliers and service providers you’d look to meet at our events.
    30 Nov 2020
  • Executive Interview with Vice President of Pharmaceutical Development on Growth and Strategy

    Brochure Executive Interview with Vice President of Pharmaceutical Development on Growth and Strategy

    When Adare Pharma Solutions was acquired in September of 2020 by two private equity firms known for activating growth and innovation, the company sent a signal to organizations that depend on contract development and manufacturing services to bring their pharma solutions to the healthcare market: if you need a trusted partner, now more than ever, Adare is a winning choice.
  • Patient-centric medicines the way forward during COVID-19 crisis, say CPHI panel

    News Patient-centric medicines the way forward during COVID-19 crisis, say CPHI panel

    Festival of Pharma roundtable discusses how drug delivery formulation and development is focused on hospital-to-home care setting
    15 Oct 2020
  • Dedicated Dialogue - Improved Drug Delivery with Precision Particle Fabrication

    Brochure Dedicated Dialogue - Improved Drug Delivery with Precision Particle Fabrication

    Precision Particle Fabrication™ technology produces uniform microspheres and microcapsules with narrow size distribution and precise control over particle structure, making the platform versatile enough to accommodate a range of active ingredients and delivery formats. Nathan H. Dormer, PhD, Director of Drug Product Development at Adare Pharma Solutions, speaks about how this new technology platform is expanding the frontiers of therapeutic delivery and improving patients’ experience in the process.
  • The latest formulation approaches for counteracting drug solubility, stability and bioavailability issues

    News The latest formulation approaches for counteracting drug solubility, stability and bioavailability issues

    What kind of enhancement solutions do CDMOs need to offer their pharma clients to address pressing issues such as bioavailability, solubility and stability of their products? A recent CPHI webinar sponsored by Adare Pharmaceuticals delved deep into the issue...
    24 Aug 2020
  • Case Study - Microcaps Exceeds Stringent Requirements Beyond Taste-Masking

    Brochure Case Study - Microcaps Exceeds Stringent Requirements Beyond Taste-Masking

    A particularly bitter pediatric macrolide in powder form was brought to Adare for needs beyond just taste masking. The API also needed: fast release due to a narrow absorption window, smooth syrup mouthfeel acceptable to children and infants, over seven days of taste masking after suspension, drug loading suitable for its high dose. How did Adare meet this challenge?
  • Case Study - Stable Microcaps Formulation Masks Bitter HIV Drug for Young Children

    Brochure Case Study - Stable Microcaps Formulation Masks Bitter HIV Drug for Young Children

    Adare Pharma Solutions was asked to create a taste masked, convenient dosage formulation of a very bitter API for patients two-years old and older undergoing treatment of HIV infection. As the drug would be administered in patient home settings, sub-optimal distribution and storage conditions, would need to be also considered as well as flexible dose requirements due to patient to patient weight and age variations.
  • Case Study - Microcaps Outperforms Standard Bead Intermediate Formulations

    Brochure Case Study - Microcaps Outperforms Standard Bead Intermediate Formulations

    A particularly bitter pediatric macrolide in powder form was brought to Adare for needs beyond just taste masking. The API also needed: fast release due to a narrow absorption window, smooth syrup mouthfeel acceptable to children and infants, over seven days of taste masking after suspension, drug loading suitable for its high dose. How did Adare meet this challenge?
  • How to Achieve Precise and Flexible Dosing with Microparticulates

    Whitepaper How to Achieve Precise and Flexible Dosing with Microparticulates

    Adare’s MMTS™ Multi Mini Tablet System platform is the embodiment of what is possible through multiparticulate technology, combining the simplicity and high drug loading capacity of tablets with the flexibility to generate a wide range of release profiles specifically suited to both patient and drug.
  • Coacervation - Expanding Solutions for Challenging APIs

    Whitepaper Coacervation - Expanding Solutions for Challenging APIs

    A variety of microencapsulation techniques are widely used in the pharmaceutical industry including fluid bed coating, spray drying, solvent evaporation, and more. However, one method—coacervation—offers several unique benefits to developers interested in working with challenging and/or bitter-tasting molecules, managing a product’s lifecycle, and even accelerating development timelines.
  • Nature's Building Blocks Access to Choice

    Video Nature's Building Blocks Access to Choice

    Access to Choice: Long Acting Injectables for Contraceptives BBC Video
    2024-07-16
  • A Guide to Successful Collaboration - Considerations When Choosing Your First CDMO as a Start-Up

    Video A Guide to Successful Collaboration - Considerations When Choosing Your First CDMO as a Start-Up

    In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist for choosing your first CDMO. Discussion Points Thinking ahead before executing – why it is essential to map out what you need to achieve in all departments Why creating a business partnership case to potential CDMOs will determine if they are the right fit for you A checklist of the common pitfalls and how to avoid
    2024-07-16
  • Taste Masking of Bitter Drugs For Pediatric Population

    Webinar Taste Masking of Bitter Drugs For Pediatric Population

    This session addresses: Pediatric population and their needs, the significance of taste masking, taste masking strategies, and Adare's taste-masking solutions. This session was broadcast as part of the CPHI North America show.
    2024-07-16